These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 328789)

  • 1. Fungicidal components of mammalian granulocytes active against Cryptococcus neoformans.
    Lehrer RI; Ladra KM
    J Infect Dis; 1977 Jul; 136(1):96-9. PubMed ID: 328789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes.
    Lehrer RI; Ladra KM; Hake RB
    Infect Immun; 1975 Jun; 11(6):1226-34. PubMed ID: 49298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.
    Diamond RD; Allison AC
    Infect Immun; 1976 Sep; 14(3):716-20. PubMed ID: 786891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental cryptococcosis in guinea pigs.
    Riera CM; Masih DT; Nobile R
    Mycopathologia; 1983 Jun; 82(3):179-84. PubMed ID: 6350885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans.
    Murphy JW; Gregory JA; Larsh HW
    Infect Immun; 1974 Feb; 9(2):404-9. PubMed ID: 4593343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis of Cryptococcus neoformans by alveolar macrophages.
    Bulmer GS; Tacker JR
    Infect Immun; 1975 Jan; 11(1):73-9. PubMed ID: 1090528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans.
    Mambula SS; Simons ER; Hastey R; Selsted ME; Levitz SM
    Infect Immun; 2000 Nov; 68(11):6257-64. PubMed ID: 11035733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microsomal fraction of Cryptococcus neoformans induces lymphocyte blastogenesis in infected guinea pigs.
    Jones AE; Reiss E; Spira TJ
    Mycopathologia; 1981 Sep; 75(3):129-38. PubMed ID: 7038506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 11. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.
    Davies SF; Clifford DP; Hoidal JR; Repine JE
    J Infect Dis; 1982 Jun; 145(6):870-4. PubMed ID: 7045251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.
    Murphy JW; Pahlavan N
    Infect Immun; 1979 Jul; 25(1):284-92. PubMed ID: 383616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRODUCTION OF INFLAMMATORY CHANGES IN THE MICROCIRCULATION BY CATIONIC PROTEINS EXTRACTED FROM LYSOSOMES.
    JANOFF A; ZWEIFACH BW
    J Exp Med; 1964 Nov; 120(5):747-64. PubMed ID: 14247717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal skin test antigen: preparation variables and characterization.
    Bennett JE
    Infect Immun; 1981 Apr; 32(1):373-80. PubMed ID: 7012033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.
    Karaoui RM; Hall NK; Larsh HW
    Mykosen; 1977 Nov; 20(11):409-12. PubMed ID: 339078
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the antigenicity of Cpl1, a surface protein of Cryptococcus neoformans var. neoformans.
    Cai JP; Liu LL; To KK; Lau CC; Woo PC; Lau SK; Guo YH; Ngan AH; Che XY; Yuen KY
    Mycologia; 2015; 107(1):39-45. PubMed ID: 25261494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of Cryptococcus neoformans & Candida species with concanavalin A & blood grouping sera.
    Mishra SK; Mishra A; Gugnani HC
    Indian J Med Res; 1990 Sep; 91():382-5. PubMed ID: 2269512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages.
    Weinberg PB; Becker S; Granger DL; Koren HS
    Am Rev Respir Dis; 1987 Nov; 136(5):1242-7. PubMed ID: 3314617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of Histoplasma capsulatum in guinea pig polymorphonuclear leukocytes.
    Howard DH
    Infect Immun; 1973 Sep; 8(3):412-9. PubMed ID: 4125783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells.
    Diamond RD
    Nature; 1974 Jan; 247(5437):148-50. PubMed ID: 4589453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.